Co-Inhibitors of Second Signal of Lymphocyte Response in Human Renal Transplants: PD-L2, GITR, and ILT-2/3/5 Positive Cells from Aspiration Biopsies Associate with Acute Rejection-Freedom — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Co-Inhibitors of Second Signal of Lymphocyte Response in Human Renal Transplants: PD-L2, GITR, and ILT-2/3/5 Positive Cells from Aspiration Biopsies Associate with Acute Rejection-Freedom
Instituto Português do Sangue e da Transplantação, área Transplantação, Rua do Bolama, Porto, Portugal
,
GCCT, Centro Hospitalar Universitário S. João, Alameda Hernani Monteiro, Porto, Portugal
,
CINTESIS, Faculdade de Medicina da Universidade do Porto, Alameda Hernani Monteiro, Porto, Portugal
1 Instituto Português do Sangue e da Transplantação, área Transplantação, Rua do Bolama, Porto, Portugal
2 GCCT, Centro Hospitalar Universitário S. João, Alameda Hernani Monteiro, Porto, Portugal
3 CINTESIS, Faculdade de Medicina da Universidade do Porto, Alameda Hernani Monteiro, Porto, Portugal
Following organ transplantation , the outcome of the encounter between an APC and a T lymphocyte is strongly dependent on the presence of costimulatory and co-inhibitory molecules, the former associated with allograft rejection and the latter with allograft acceptance. We evaluated the expression of PD-L2, GITR, ILT-2/3/5, and ILT-4 on graft-infiltrating cells procured by Fnab from human KTx under different immunosuppressive regimens. Methods: Fnab biopsies were performed on days 7 or 14 - 30 in stable KTx and on the day of acute rejection diagnosis. Cytopreparations were studied by the enzymatic avidin biotin complex staining. Results: Acute rejection group showed a significant down-regulated expression of PD-L2, GITR, and ILT-2/3/5 as compared to stable group, while for ILT-4 we did not find significant difference. Anti-IL2 α R and rapamicyn treatment trend to down-regulate ILT-4 expression, although meaningless. A significant ly positive correlation was observed between PD-L2 and GITR expression in Fnab. The PPV for acute rejection diagnosis for both PD-L2 and GITR w as clearly above 0.8. Conclusions: Our findings point to an early entrance of cells expressing PD-L2, GITR and ILT-2/3/5 inside human KTx who are going to remain rejection-free. Both PD-L2 and GITR shared a high ability to rule-in and rule-out acute rejection.
Medawar, P.B. (1944) The Behaviour and Fate of Skin Autografts and Skin Homografts in Rabbits. Journal of Anatomy, 78, 176-199.
Hart, A., Smith, J.M., Skeans, M.A., et al. (2019) OPTN/SRTR 2017 Annual Data Report: Kidney. American Journal of Transplantation, 19, 19-123. https://doi.org/10.1111/ajt.15274
Sellarés, J., de Freitas, D.G., Mengel, M., et al. (2012) Understanding the Causes of Kidney Transplant Failure, the Dominant Role of Antibody-Mediated Rejection and Nonadherence. American Journal of Transplantation, 12, 388. https://doi.org/10.1111/j.1600-6143.2011.03840.x
Barrett, A.J., Rezvani, K., Solomon, S., et al. (2003) New Developments in Allotransplant Immunology. Hematology ASH Education Program, 102, 350. https://doi.org/10.1182/asheducation-2003.1.350
Lafferty, K.J. and Woolnough, J. (1977) The Origin and Mechanism of the Allograft Reaction. Immunological Reviews, 35, 231-262. https://doi.org/10.1111/j.1600-065X.1977.tb00241.x
Shipkova, M. and Wieland, E. (2012) Surface Markers of Lymphocyte Activation and Markers of Cell Proliferation. Clinica Chimica Acta, 413, 1338-1349. https://doi.org/10.1016/j.cca.2011.11.006
Bakdash, G., Sittig, S., van Dijk, T., Figuredor, C.G. and de Vries, J.M. (2013) The Nature of Activatory and Tolerogenic Dendritic Cell-Derived Signal II. Frontiers in Immunology, 4, 53. https://doi.org/10.3389/fimmu.2013.00053
Marin, E., Cuturi, M.C. and Moreau, A. (2018) Tolerogenic Dendritic Cells in Solid Organ Transplantation, Where Do We Stand? Frontiers in Immunology, 9, 274. https://doi.org/10.3389/fimmu.2018.00274
Braza, F., Durand, M., Degauque, N. and Brouard, S. (2015) Regulatory T Cells in Kidney Transplantation: New Directions? American Journal of Transplantation, 15, 2288-2300. https://doi.org/10.1111/ajt.13395
Puccetti, P. and Grohmann, U. (2007) IDO and Regulatory T Cells, a Role for Reverse Signalling and Non-Canonical NF-B Activation. Nature Reviews Immunology, 7, 817-823. https://doi.org/10.1038/nri2163
Truong, W., Hancock, W.W., Anderson, C.C., Merani, S. and Shapiro, M.J. (2006) Coinhibitory T-Cell Signalling in Islet Allograft Rejection and Tolerance. Cell Transplantation, 15, 105-119. https://doi.org/10.3727/000000006783982160
Bajwa, R., Cheema, A., Khan, T., et al. (2019) Adverse Effects of Immune Checkpoint Inhibitors (Programmed Death-1 Inhibitors and Cytotoxic T-Lymphocyte-Associated Protein-4 Inhibitors): Results of a Retrospective Study. Journal of Clinical Medicine Research, 11, 225-236. https://doi.org/10.14740/jocmr3750
del Rio, M.-L., Buhler, L., Gibbond, C., Tian, J. and Rodriguez-Barbosa, J.-I. (2008) PD-1/PD-L1, PD-1/PD-L2 and Other Co-Inhibitory Signalling Pathways in Transplantation. Transplant International, 21, 1015-1028. https://doi.org/10.1111/j.1432-2277.2008.00726.x
Fedoric, B. and Krishnan, R. (2008) Rapamycin Downregulates the Inhibitory Receptors ILT2, ILT3, ILT4 on Human Dendritic Cells and Yet Induces T Cell Hyporesponsiveness Independent of FoxP3 Induction. Immunology Letters, 120, 49-56. https://doi.org/10.1016/j.imlet.2008.06.009
Haÿry, P. (1989) Fine-Needle Aspiration Biopsy in Renal Transplantation. Kidney International, 36, 130. https://doi.org/10.1038/ki.1989.172
Xavier, P.D.P., Lema, G.L., Magalhães, M.C., et al. (2014) Flow Cytometry Assessment of Graft-Infiltrating Lymphocytes Can Accurately Identify Acute Rejection in Kidney Transplants. Clinical Transplantation, 28, 177-183. https://doi.org/10.1111/ctr.12293
Oliveira, J.G.G., Ramos, J.P., Xavier, P., Magalhães, M.C., Mendes, A.A. and Guerra, L.E.R. (1997) Analysis of Fine-Needle Aspiration Biopsies by Flow Cytometry in Kidney Transplant Patients. Transplantation, 64, 97-102. https://doi.org/10.1097/00007890-199707150-00018
Blank, C., Brown, L., Marks, R., Nishimura, H., Honjo, T. and Gajewski, T.F. (2003) Absence of Programmed Death Receptor 1 Alters Thymic Development and Enhances Generation of CD4/CD8 Double-Negative TCR-Transgenic T Cells. The Journal of Immunology, 171, 4574-4581. https://doi.org/10.4049/jimmunol.171.9.4574
Probst, H.C., McCoy, K., Okazaki, T., Honjo, T. and van den Broek, M. (2005) Resting Dendritic Cells Induce Peripheral CD8+T Cell Tolerance through PD-1 and CTLA-4. Nature Immunology, 6, 280-286. https://doi.org/10.1038/ni1165
Keir, M.E., Liang, S.C., Guleria, I., et al. (2006) Tissue Expression of PD-L1 Mediates Peripheral T Cell Tolerance. Journal of Experimental Medicine, 203, 883-895. https://doi.org/10.1084/jem.20051776
Fife, B.T., Pauken, K.E., Eagar, T.N., et al. (2009) Interactions between PD-1 and PD-L1 Promote Tolerance by Blocking the TCR-Induced Stop Signal. Nature Immunology, 10, 1185-1192. https://doi.org/10.1038/ni.1790
Lesterhuis, W.J., Punt, C.J., Hato, S.V., et al. (2011) Platinum-Based Drugs Disrupt STAT6-Mediated Suppression of Immune Responses against Cancer in Humans and Mice. Journal of Clinical Investigation, 121, 3100-3108. https://doi.org/10.1172/JCI43656
Peng, W., Ran, B., Ma, Y., Huang, X., Chang, Q. and Wang, X. (2011) Dendritic Cells Transfected with PD-L1 Recombinant Adenovirus Induces T Cell Suppression and Long-Term Acceptance of Allograft Transplantation. Cellular Immunology, 271, 73-77. https://doi.org/10.1016/j.cellimm.2011.06.007
Starke, A., Lindenmeyer, M.T., Segerer, S., et al. (2010) Renal Tubular PD-L1 (CD274) Suppresses Alloreactive Human T-Cell Responses. Kidney International, 78, 38-47. https://doi.org/10.1038/ki.2010.97
Nguyen, L.T., Radhakrihnan, S., Ciric, B., et al. (2002) Cross-Linking the B7 Family Molecule B7-DC Directly Activates Immune Functions of Dendritic Cells. Journal of Experimental Medicine, 196, 1393-1398. https://doi.org/10.1084/jem.20021466
Radhakrihnan, S., Nguyen, L.T., Ciric, B., et al. (2003) Naturally Occurring Human IgM Antibody That Binds B7-DC and Potentiates T Cell Stimulation by Dendritic Cells. The Journal of Immunology, 170, 1830-1838. https://doi.org/10.4049/jimmunol.170.4.1830
Shin, T., Yoshimura, K., Shin, T., et al. (2005) In Vivo Costimulatory Role of B7-DC in Tuning T Helper Cell 1 and Cytotoxic T Lymphocyte Responses. Journal of Experimental Medicine, 201, 1531-1541. https://doi.org/10.1084/jem.20050072
Salama, A.D., Chitnis, T., Imitola, J., et al. (2003) Critical Role of Programmed Death-1 (PD-1) Pathway in Regulation of Experimental Autoimmune Encephalomyelitis. Journal of Experimental Medicine, 198, 71-78. https://doi.org/10.1084/jem.20022119
Zhang, Y., Chung, Y., Bishop, C., et al. (2006) Regulation of T Cell Activation and Tolerance by PDL2. Proceedings of the National Academy of Sciences of the United States of America, 103, 11695-11700. https://doi.org/10.1073/pnas.0601347103
Greenwald, R.J., Freeman, G.J. and Sharpe, A.H. (2005) The B7 Family Revisited. Annual Review of Immunology, 23, 515-548. https://doi.org/10.1146/annurev.immunol.23.021704.115611
Butte, M.J., Keir, M.E., Phamduy, T.B., Sharpe, A.H. and Freeman, G.J. (2007) Programmed Death-1 Ligand 1 Interacts Specifically with the B7-1 Costimulatory Molecule to Inhibit T Cell Responses. Immunity, 27, 111-122. https://doi.org/10.1016/j.immuni.2007.05.016
Patsoukis, N., Brown, J., Petkova, V., Liu, F., Li, L. and Boussiotis, V.A. (2012) Selective Effects of PD-1 on Akt and Ras Pathways Regulate Molecular Components of the Cell Cycle and Inhibit T Cell Proliferation. Science Signaling, 5, ra46. https://doi.org/10.1126/scisignal.2002796
Chemnitz, J.M., Parry, R.V., Nichols, K.E., June, C.H. and Riley, J.I. (2004) SHP-1 and SHP-2 Associate with Immunoreceptor Tyrosine-Based Switch Motif of Programmed Death 1 upon Primary Human T Cell Stimulation, But Only Receptor Ligation Prevents T Cell Activation. The Journal of Immunology, 173, 945-954. https://doi.org/10.4049/jimmunol.173.2.945
Latchman, Y., Wood, R.C., Chernova, T., et al. (2001) PD-L2 Is a Second Ligand for PD-1 and Inhibits T Cell Activation. Nature Immunology, 2, 261-268. https://doi.org/10.1038/85330
Riella, L.V., Paterson, A.M., Sharpe, A.H. and Chandraker, A. (2012) Role of the PD-1 Pathway in the Immune Response. American Journal of Transplantation, 12, 2575-2587. https://doi.org/10.1111/j.1600-6143.2012.04224.x
Afaneh, C., Muthukumar, T., Lubetzky, M., et al. (2010) Urinary Cell Levels of mRNA for OX40, OX40L, OD-1, PD-L1 or PD-L2 and Acute Rejection of Human Renal Allografts. Transplantation, 90, 1381-1387. https://doi.org/10.1097/TP.0b013e3181ffbadd
McHugh, R.S., Whitters, M.J., Piccirillo, C.A., Young, D.A., Shevach, E.M., Collins, M. and Byrne, M.C. (2002) CD4(+)CD25(+) Immunoregulatory T Cells, Gene Expression Analysis Reveals a Functional Role for the Glucocorticoid-Induced TNF Receptor. Immunity, 16, 311-323. https://doi.org/10.1016/S1074-7613(02)00280-7
Miyara, M., Yoshioka, Y., Kitoh, A., et al. (2009) Functional Delineation and Differentiation Dynamics of Human CD4+T Cells Expressing the FoxP3 Transcription Factor. Immunity, 30, 899-911. https://doi.org/10.1016/j.immuni.2009.03.019
Valmori, D., Merlo, A., Souleimanian, N.E., Hesdorffer, C.S. and Ayyoub, M. (2005) A Peripheral Circulating Compartment of Natural NaÏve CD4 Tregs. Journal of Clinical Investigation, 115, 1953-1962. https://doi.org/10.1172/JCI23963
Schoenhals, J.E., Cushman, T.R., Barsoumian, H.B., et al. (2018) Anti-Glucocorticoid-Induced Tumor Necrosis Factor-Related Protein (GITR) Therapy Overcomes Radiation-Induced Treg Immunosuppression and Drives Abscopal Effects. Frontiers in Immunology, 9, 2170. https://doi.org/10.3389/fimmu.2018.02170
Nocentini, G., Ronchetti, S., Cuzzocrea, S. and Riccardi, C. (2007) GITR/GITRL, More than an Effector T Cell Costimulatory System. European Journal of Immunology, 37, 1165-1169. https://doi.org/10.1002/eji.200636933
Li, Y., Yang, S., Li, Z., Meng, H., Jin, W., Yang, H. and Yin, W. (2019) Soluble Glucorcoticoid-Induced Tumor Necrosis Factor Receptor Regulates Helios Expression in Myasthenia Gravis. Journal of Translational Medicine, 17, 168-177. https://doi.org/10.1186/s12967-019-1916-1
Zhang, M., Wan, J., Xu, Y., et al. (2017) Simultaneously Increased Expression of Glucocorticoid-Induced Tumor Necrosis Factor Receptor and Its Ligand Contributes to Increased Interleukin-5/13-Producing Group 2 Innate Lymphocytes in Murine Asthma. Molecular Medicine Reports, 15, 4291-4299. https://doi.org/10.3892/mmr.2017.6500
Liao, G., Nayak, S., Regueiro, J.R., et al. (2010) GITR Engagement Preferentially Rnhances Proliferation of Functionally Competent CD4+CD25+FoxP3+ Regulatory T Cells. International Immunology, 22, 259-270. https://doi.org/10.1093/intimm/dxq001
Clouthier, D.L. and Watts, T.H. (2014) Cell-Specific and Context-Dependent Effects of GITR in Cancer, Autoimmunity, and Infection. Cytokine & Growth Factor Reviews, 25, 91-106. https://doi.org/10.1016/j.cytogfr.2013.12.003
Kim, J.I., Sonawane, S.B., Lee, M.L., et al. (2010) Blockade of GITR-GITRL Interaction Maintains Treg Function to Prolong Allograft Survival. European Journal of Immunology, 40, 1369-1374. https://doi.org/10.1002/eji.200940046
Fu, Z., Wang, S., Li, J., Zhang, Y., Li, H., Li, G., Wan, X. and Zhang, Y. (2020) Biological Role of GITR/GITRL in Attributes and Immune Responses of Macrophage. Journal of Leukocyte Biology, 107, 309-321. https://doi.org/10.1002/JLB.3A0919-387RR
Knee, D.A., Hewes, B. and Brogdon, J.L. (2016) Rationale for Anti-GITR Cancer Immunotherapy. European Journal of Cancer, 67, 1-10. https://doi.org/10.1016/j.ejca.2016.06.028
Galle-Treger, Snakaranarayanan, I., Hurrell, B.P., et al. (2019) Costimulation of Type-2 Inate Lymphoid Cells by GITR Promotes Effector Function and Ameliorates Type 2 Diabetes. Nature Communications, 10, 713. https://doi.org/10.1038/s41467-019-08449-x
Karimi, M., Ahmadpoor, P., Nafar, M., Pourrezagholi, F., Jamali, S., Eteghadi, A., Yekaninejad, M.S. and Amirzargar, A.A. (2020) Frequency of Dendritic Cell Subsets and ILT3, ILT4 Gene Expression in Two Different Immunosuppressive Protocols in Kidney Transplant Recipients. A Cohort Report. Molecular Biology Reports, 47, 123-128. https://doi.org/10.1007/s11033-019-05113-x
Stallone, G., Pontrelli, P., Infante, B., Gigante, M., Netti, G., Ranieri, E., Grandaliano, G. and Gesualdo, L. (2014) Rapamycin Induces ILT3high and ILT4high Dendritic Cells Promoting a New Immunoregulatory Pathway. Kidney International, 85, 888-897. https://doi.org/10.1038/ki.2013.337
Yokoyama, W.M. (1997) What Goes Up Must Come Down, the Emerging Spectrum of Inhibitory Receptors. Journal of Experimental Medicine, 186, 1803-1808. https://doi.org/10.1084/jem.186.11.1803
Shiroishi, M., Tsumoto, K., Amano, K., et al. (2003) Human Inhibitory Receptors Ig-Like Transcript 2 (ILT2) and ILT4 Compete with CD8 for MHC Class I Binding and Bind Preferentially to HLA-G. Proceedings of the National Academy of Sciences of the United States of America, 100, 8856-8861. https://doi.org/10.1073/pnas.1431057100
Beinhauer, B.G., McBride, J.M., Graf, P., et al. (2004) Interleukin 10 Regulates Cell Surface and Soluble LIR-2 (CD85d) Expression on Dendritic Cells Resulting in T Cell Hyporesponsiveness in Vitro. European Journal of Immunology, 34, 74-80. https://doi.org/10.1002/eji.200324550
Manavalan, J.S., Rossi, P.C., Vlad, G., et al. (2003) High Expression of ILT3 and ILT4 Is a General Feature of Tolerogenic Dendritic Cells. Transplant Immunology, 11, 245-258. https://doi.org/10.1016/S0966-3274(03)00058-3
Li, D., Wang, L., Yu, L., Freundt, E.C., Jin, B., Screaton, G.R. and Xu, X.-N. (2009) Immunoglobulin-Like Transcript 4 (ILT4) Inhibits Lipid Antigen Presentation through Direct CD1d Interaction. The Journal of Immunology, 15, 1033-1040. https://doi.org/10.4049/jimmunol.182.2.1033
Cella, M., Döhring, C., Samaridis, J., Dessing, M., Brockhaus, M., Lanzavecchia, A. and Colonna, M. (1997) A Novel Inhibitory Receptor (ILT3) Expressed on Monocytes, Macrphages, and Dendritic Cells Involved in Antigen Processing. Journal of Experimental Medicine, 10, 1743-1751. https://doi.org/10.1084/jem.185.10.1743
Monsiváis-Urenda, A., Niño-Moreno, P., Abud-Mendoza, C., et al. (2007) Analysis of Expression and Function of the Inhibitory Receptor ILT2 (CD85j/LILRB1/LIR-1) in Peripheral Blood Mononuclear Cells from Patients with Systemic Lupus Erythematosus (SLE). Journal of Autoimmunity, 29, 97-105. https://doi.org/10.1016/j.jaut.2007.05.003
Guerra-de-Blas, P., Villaseñor-Talavera, Y.S., Cruz-González, D.J., Baranda, L., Doníz-Padilla, L., Abud-Mendoza, C., González-Amaro, R. and Monsiváis-Urenda, A.E. (2016) Analysis of the Expression and Function of Immunoglobulin-Like Transcript 4 (ILT4, LILRB2) in Dendritic Cells from Patients with Systemic Lúpus Erythematosus. Journal of Immunology Research, 7, 1-13. https://doi.org/10.1155/2016/4163094
Sun, Y., Liu, J., Gao, P., Wang, Y. and Liu, C. (2008) Expression of Ig-Like Transcript 4 Inhibitory Receptor in Human Non-Small Cell Lung Cancer. Chest, 134, 783-788. https://doi.org/10.1378/chest.07-1100
Manavalan, J.S., Kim-Sculze, S., Scotto, L., et al. (2004) Alloantigen Specific CD8+CD28-FOXP3+ T Suppressor Cells Induce ILT3+ILT4+ Tolerogenic Endothelial Cells, Inhibiting Alloreactivity. International Immunology, 16, 1055-1068. https://doi.org/10.1093/intimm/dxh107
Oliveira, G., Xavier, P., Murphy, B., Neto, S., Mendes, A., Sayegh, M.H. and Guerra, L.E. (1998) Cytokine Analysis of Human Renal Allograft Aspiration Biopsy Cultures Supernatants Predicts Acute Rejection. Nephrology Dialysis Transplantation, 13, 417-422. https://doi.org/10.1093/oxfordjournals.ndt.a027839